Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Pfizer Inc (PFE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 217,041,632
  • Shares Outstanding, K 5,952,870
  • Annual Sales, $ 52,546 M
  • Annual Income, $ 21,308 M
  • 36-Month Beta 0.91
  • Price/Sales 4.10
  • Price/Cash Flow 9.70
  • Price/Book 3.07

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.32 +2.60%
on 05/29/18
36.80 -1.52%
on 06/11/18
+0.44 (+1.23%)
since 05/21/18
3-Month
34.32 +5.59%
on 03/26/18
37.26 -2.75%
on 04/24/18
-0.03 (-0.08%)
since 03/21/18
52-Week
32.32 +12.13%
on 08/21/17
39.43 -8.09%
on 01/29/18
+2.36 (+6.97%)
since 06/21/17

Most Recent Stories

More News
How Long Should You Own a Stock?

These 4 criteria can guide investors through the investing maze.

SBUX : 50.65 (-3.01%)
XOM : 79.74 (-0.88%)
PFE : 36.29 (-0.47%)
GE : 12.74 (-1.09%)
TR : 30.45 (-0.16%)
Amgen Gets EU Nod to Add Survival Data on Blincyto's Label

Amgen (AMGN) gets approval from the European Commission to add overall survival (OS) data from the TOWER study on the label of its leukemia drug, Blincyto.

CRSP : 65.23 (-0.05%)
GHDX : 51.60 (-0.54%)
AMGN : 185.46 (-0.56%)
PFE : 36.29 (-0.47%)
Pfizer Inc (PFE) Crosses Pivot Point Resistance at $36.43

Shares of Pfizer Inc (NYSE:PFE) opened today above their pivot of $36.15 and have already reached the first level of resistance at $36.43. Investors may be interested in a cross of the next upside pivot...

PFE : 36.29 (-0.47%)
Sarepta's Stock Soars on Encouraging Gene Therapy Results

Sarepta (SRPT) shares skyrocket on better-than-expected results from an early-stage study, evaluating its gene therapy as a treatment for DMD patients.

PTCT : 35.86 (+0.62%)
SLDB : 39.95 (+12.00%)
SRPT : 150.31 (-2.20%)
PFE : 36.29 (-0.47%)
The Dow then and now: original, current members of index

NEW YORK (AP) — S&P Dow Jones Indices announced Tuesday that General Electric would be replaced in the Dow Jones industrial average by Walgreens Boots Alliance.

CVX : 123.24 (-1.64%)
JNJ : 121.73 (-0.25%)
PG : 76.50 (+0.86%)
PFE : 36.29 (-0.47%)
BA : 337.71 (-1.45%)
Myriad Genetics Wins FDA SPMA Nod for BRACAnalysis CDx

The FDA accepts Myriad Genetics' (MYGN) supplementary premarket approval (sPMA) application for BRACAnalysis CDx to identify the best responders to Pfizer's PARP inhibitor, talazoparib.

AZN : 35.14 (-2.74%)
MRK : 61.08 (-0.33%)
MYGN : 39.09 (+0.10%)
PFE : 36.29 (-0.47%)
Pfizer Invites Public To View And Listen To Webcast Of July 31 Conference Call With Analysts

Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, July 31, 2018. The purpose of...

PFE : 36.29 (-0.47%)
Look for Shares of Pfizer Inc to Potentially Rebound after Yesterday's 1.13% Sell Off

Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $35.73 to a high of $36.22. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $36.03 on...

PFE : 36.29 (-0.47%)
Pfizer Inc Set to Possibly Rebound After Yesterday's Selloff of 1.13%

Pfizer Inc (NYSE:PFE) traded in a range yesterday that spanned from a low of $35.73 to a high of $36.22. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $36.03 on...

PFE : 36.29 (-0.47%)
Glaxo Two-Drug HIV Combo Meets Primary Endpoint in Phase III

Glaxo's (GSK) two late-stage studies testing its two-drug HIV regimen of dolutegravir (Tivicay) and lamivudine showed non-inferiority to a standard three-drug regimen

MYL : 38.65 (-0.57%)
JNJ : 121.73 (-0.25%)
PFE : 36.29 (-0.47%)
GSK : 40.83 (-0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade PFE with:

Business Summary

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional...

See More

Key Turning Points

2nd Resistance Point 36.79
1st Resistance Point 36.62
Last Price 36.29
1st Support Level 36.25
2nd Support Level 36.05

See More

52-Week High 39.43
Fibonacci 61.8% 36.71
Last Price 36.29
Fibonacci 50% 35.88
Fibonacci 38.2% 35.04
52-Week Low 32.32

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar